Featured news in The Life Sciences Report



Athersys Inc. (ATHX:NASDAQ)
Athersys Hikes on MultiStem Hookup with Japanese Firm (10/11/2017)

view
 

Athersys Inc. (ATHX:NASDAQ)
Athersys (ATHX) in Focus: Stock Moves 7.2% Higher (10/12/2017)

view
 

Athersys Inc. (ATHX:NASDAQ)
NetworkNewsBreaks - Top 10 Mid-day Percentage Gainers on October 11, 2017 (10/11/2017)

view
 


ProMIS Neurosciences Inc. (PMN:TSE)
Provides Third Quarter Update for 2017 (10/11/2017)

view
 


Athersys Inc. (ATHX:NASDAQ)
Athersys and Nikon CeLL Innovation to Collaborate on MultiStem® Commercial Manufacturing in Japan (10/11/2017)

view
 


RXi Pharmaceuticals Corp. (RXII:NASDAQ)
RXi Pharmaceuticals to Present at the 2017 Annual BIO Investor Forum (10/11/2017)

view
 


Celgene Corp. (CELG:NASDAQ)
Mallinckrodt to Begin Sarcoidosis Study on Acthar Gel (10/10/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
Amgen Label Expansion Application for Prolia Accepted by FDA (10/10/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
Biotech Stock Roundup: Amgen's Imlygic Data Promising, Regeneron Scores Win in PCSK9 Lawsuit (10/11/2017)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
Multicenter Randomized Controlled VLU Clinical Study Published in the International Wound Journal Demonstrates Significantly Higher Healing Rates of MiMedx EpiFix® (10/11/2017)

view
 

MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Group (MDXG) Looks Good: Stock Adds 5.4% in Session (10/11/2017)

view
 


Viveve Medical Inc. (VIVE:NASDAQ)
Viveve Announces Regulatory Approval for Viveve System in Taiwan (10/10/2017)

view
 


3D Signatures Inc. (DXD:TSX.V; TDSGF:OTCQB; 3D0:FSE)
3D Signatures Announces Completion of Stage 3 of Hodgkin's Lymphoma Test Validation Program (10/10/2017)

view
 


Celgene Corp. (CELG:NASDAQ)
Strategic Research Analysis ­ Positioning to Benefit on  Abbott, Rite Aid, Kroger, Celgene, Twitter, and NIKE ­ Effects of Key Drivers of Growth and Emerging Market Trends (10/10/2017)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Seller Attacks (10/10/2017)

view
 

MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Announces Third Quarter Revenues Of $84.6 Million Exceeds Guidance By More Than 5 Percent (10/10/2017)

view